Fig. 2From: Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trialsPrimary efficacy endpoint – incidence of VTE. aChi square test. VTE = venous thromboembolismBack to article page